Abstract:It is notorious that cancer cells alter their metabolism to adjust to harsh environments of hypoxia and nutritional starvation. Metabolic reprogramming most often occurs in the tumor microenvironment (TME). TME is defined as the cellular environment in which the tumor resides. This includes surrounding blood vessels, fibroblasts, immune cells, signaling molecules and the extracellular matrix (ECM). It is increasingly recognized that cancer cells, fibroblasts and immune cells within TME can regulate tumor progression through metabolic reprogramming. As the most significant proportion of cells among all the stromal cells that constitute TME, cancer-associated fibroblasts (CAFs) are closely associated with tumorigenesis and progression. Multitudinous studies have shown that CAFs participate in and promote tumor metabolic reprogramming and exert regulatory effects via the dysregulation of metabolic pathways. Previous studies have demonstrated that curbing the substance exchange between CAFs and tumor cells can dramatically restrain tumor growth. Emerging studies suggest that CAFs within the TME have emerged as important determinants of metabolic reprogramming. Metabolic reprogramming also occurs in the metabolic pattern of immune cells. In the meanwhile, immune cell phenotype and functions are metabolically regulated. Notably, immune cell functions influenced by metabolic programs may ultimately lead to alterations in tumor immunity. Despite the fact that multiple previous researches have been devoted to studying the interplays between different cells in the tumor microenvironment, the complicated relationship between CAFs and immune cells and implications of metabolic reprogramming remains unknown and requires further investigation. In this review, we discuss our current comprehension of metabolic reprogramming of CAFs and immune cells (mainly glucose, amino acid, and lipid metabolism) and crosstalk between them that induces immune responses, and we also highlight their contributions to tumorigenesis and progression. Furthermore, we underscore potential therapeutic opportunities arising from metabolism dysregulation and metabolic crosstalk, focusing on strategies targeting CAFs and immune cell metabolic crosstalk in cancer immunotherapy.

Emerging Landscapes of Tumor Immunity and Metabolism

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

The cancer metabolic reprogramming and immune response

Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy

The Role of Tumor Metabolic Reprogramming in Tumor Immunity

Metabolic interventions: A new insight into the cancer immunotherapy

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications

Targeting metabolism to enhance immunotherapy within tumor microenvironment

Metabolic Manipulation of the Tumour Immune Microenvironment

Editorial: Tumor microenvironment and metabolic reprogramming in cancer

Immunosurveillance encounters cancer metabolism

Regulation of Cancer Metabolic Reprogramming on Immune Microenvironment

Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy

Macrophages and Metabolic Reprograming in the Tumor Microenvironment

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment

Metabolic regulation in the immune response to cancer

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment

Metabolic reprogramming in the tumor microenvironment of liver cancer

Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment